VONOPRAZAN FUMARATE

VONOPRAZAN FUMARATE was reported 8132 times

VONOPRAZAN FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERGASTRINAEMIA 10 0.0813
1 BLOOD GASTRIN INCREASED 8 0.0625
2 IMMOBILISATION SYNDROME 8 0.0376
3 GASTRIC MUCOSAL HYPERTROPHY 9 0.0364
4 HERNIA HIATUS REPAIR 7 0.0343
5 IMMUNE-MEDIATED CHOLANGITIS 12 0.0334
6 KL-6 INCREASED 7 0.0310
7 SUSPECTED DRUG-INDUCED LIVER INJURY 6 0.0300
8 GASTROINTESTINAL POLYP HAEMORRHAGE 18 0.0298
9 OESOPHAGOGASTRIC FUNDOPLASTY 5 0.0294
10 MESENTERIC ARTERIAL OCCLUSION 4 0.0284
11 IMMUNE-MEDIATED GASTRITIS 5 0.0260
12 THROMBOPHLEBITIS MIGRANS 8 0.0235
13 ZINC DEFICIENCY 5 0.0233
14 FULMINANT TYPE 1 DIABETES MELLITUS 23 0.0223
15 IMMUNE-MEDIATED ENCEPHALITIS 10 0.0189
16 IMMUNE-MEDIATED MYASTHENIA GRAVIS 6 0.0185
17 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 16 0.0182
18 DYSLALIA 13 0.0179
19 SHUNT OCCLUSION 9 0.0177
20 VITAMIN B1 DEFICIENCY 7 0.0164
21 IMMUNE-MEDIATED HEPATIC DISORDER 28 0.0143
22 GASTROINTESTINAL MICROORGANISM OVERGROWTH 5 0.0142
23 PUTAMEN HAEMORRHAGE 4 0.0140
24 ASPERGILLUS TEST POSITIVE 4 0.0130
25 GASTRITIS BACTERIAL 6 0.0129
26 ECZEMA ASTEATOTIC 6 0.0127
27 IMMUNE-MEDIATED ENTEROCOLITIS 46 0.0125
28 GASTRIC POLYPS 28 0.0124
29 BLOOD CORTICOTROPHIN DECREASED 6 0.0123
30 IMMUNE-MEDIATED LUNG DISEASE 22 0.0121
31 CHOLANGITIS ACUTE 9 0.0119
32 HEAT ILLNESS 8 0.0119
33 MARASMUS 18 0.0118
34 GASTRIC ANTRAL VASCULAR ECTASIA 6 0.0113
35 PHYSICAL DECONDITIONING 29 0.0113
36 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 4 0.0109
37 MECHANICAL ILEUS 6 0.0105
38 IMMUNE-MEDIATED ARTHRITIS 4 0.0105
39 CYTOMEGALOVIRUS ENTEROCOLITIS 8 0.0104
40 RENAL SALT-WASTING SYNDROME 4 0.0102
41 BILIARY TRACT INFECTION 6 0.0096
42 EROSIVE OESOPHAGITIS 16 0.0094
43 IMMUNE-MEDIATED HEPATITIS 19 0.0093
44 UPPER RESPIRATORY TRACT INFLAMMATION 11 0.0092
45 VANISHING BILE DUCT SYNDROME 10 0.0090
46 IMMUNE-MEDIATED DERMATITIS 9 0.0089
47 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 7 0.0088
48 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 4 0.0085
49 PRIMARY BILIARY CHOLANGITIS 4 0.0085
50 OESOPHAGEAL ADENOCARCINOMA 4 0.0084
51 PULMONARY TOXICITY 58 0.0082
52 IMMUNE-MEDIATED MYOCARDITIS 13 0.0080
53 STEROID DIABETES 12 0.0080
54 LYMPHANGIOSIS CARCINOMATOSA 8 0.0077
55 CHOLANGITIS 47 0.0076
56 IMMUNE-MEDIATED HYPOTHYROIDISM 8 0.0071
57 PRERENAL FAILURE 10 0.0071
58 ENTEROCOLITIS 40 0.0069
59 HYPOPITUITARISM 12 0.0069
60 STOMA COMPLICATION 7 0.0069
61 OESOPHAGEAL IRRITATION 4 0.0069
62 SYSTEMIC SCLERODERMA 5 0.0069
63 GASTRIC MUCOSAL LESION 5 0.0069
64 LUNG OPACITY 18 0.0068
65 URETEROLITHIASIS 7 0.0067
66 OESOPHAGEAL DISCOMFORT 5 0.0066
67 COLITIS MICROSCOPIC 31 0.0065
68 RADIATION PNEUMONITIS 14 0.0065
69 SQUAMOUS CELL CARCINOMA OF LUNG 5 0.0065
70 APLASIA PURE RED CELL 22 0.0064
71 INHIBITORY DRUG INTERACTION 10 0.0063
72 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
73 PNEUMONIA BACTERIAL 57 0.0062
74 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
75 OESOPHAGEAL PAIN 24 0.0061
76 EMBOLIC CEREBRAL INFARCTION 4 0.0060
77 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 4 0.0060
78 OESOPHAGEAL CANDIDIASIS 24 0.0060
79 ENTERITIS INFECTIOUS 10 0.0059
80 CARDIAC FAILURE CHRONIC 25 0.0059
81 CHOLANGITIS SCLEROSING 12 0.0058
82 PNEUMONIA CYTOMEGALOVIRAL 11 0.0057
83 GASTROINTESTINAL OEDEMA 10 0.0057
84 TUMOUR HAEMORRHAGE 16 0.0056
85 KETOSIS 6 0.0055
86 CARDIAC AMYLOIDOSIS 6 0.0054
87 ADENOCARCINOMA GASTRIC 5 0.0054
88 IMMUNE-MEDIATED ADVERSE REACTION 8 0.0052
89 ALOPECIA AREATA 9 0.0051
90 SPUTUM RETENTION 5 0.0050
91 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
92 BILE DUCT STONE 16 0.0050
93 NEUROENDOCRINE TUMOUR 7 0.0049
94 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 10 0.0049
95 ENTEROCOLITIS HAEMORRHAGIC 7 0.0047
96 CARDIAC FAILURE ACUTE 31 0.0046
97 INFECTIOUS PLEURAL EFFUSION 7 0.0046
98 BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0045
99 ORGANISING PNEUMONIA 22 0.0044
100 HYPOALBUMINAEMIA 34 0.0044
101 IMMUNE-MEDIATED MYOSITIS 12 0.0043
102 SMALL INTESTINAL PERFORATION 8 0.0043
103 RECTAL ULCER 5 0.0043
104 PNEUMONIA CRYPTOCOCCAL 4 0.0042
105 BRAIN STEM HAEMORRHAGE 4 0.0042
106 CEREBELLAR HAEMORRHAGE 6 0.0042
107 INVESTIGATION ABNORMAL 6 0.0042
108 INTERSTITIAL LUNG DISEASE 201 0.0041
109 COMPRESSION FRACTURE 22 0.0041
110 STOMA SITE PAIN 6 0.0041
111 CEREBRAL INFARCTION 98 0.0040
112 GASTROOESOPHAGEAL REFLUX DISEASE 322 0.0040
113 THYROIDITIS 12 0.0040
114 HEPATIC FUNCTION ABNORMAL 149 0.0040
115 CHRONIC GASTRITIS 9 0.0040
116 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
117 CANCER PAIN 10 0.0039
118 ATRIAL THROMBOSIS 8 0.0039
119 PRODUCT BLISTER PACKAGING ISSUE 4 0.0038
120 DUODENAL ULCER HAEMORRHAGE 11 0.0038
121 SINUS NODE DYSFUNCTION 7 0.0038
122 ADRENAL INSUFFICIENCY 46 0.0038
123 OESOPHAGEAL HAEMORRHAGE 5 0.0038
124 NON-SMALL CELL LUNG CANCER 18 0.0038
125 NEUROMYELITIS OPTICA SPECTRUM DISORDER 5 0.0037
126 JAUNDICE CHOLESTATIC 13 0.0037
127 OESOPHAGITIS 40 0.0037
128 HYPERURICAEMIA 15 0.0036
129 ADRENAL DISORDER 7 0.0036
130 PNEUMONIA ASPIRATION 90 0.0036
131 MYASTHENIA GRAVIS 29 0.0036
132 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
133 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
134 IMMUNE THROMBOCYTOPENIA 16 0.0035
135 REGURGITATION 12 0.0035
136 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
137 POST HERPETIC NEURALGIA 5 0.0035
138 PAROTITIS 4 0.0034
139 VERTIGO POSITIONAL 6 0.0034
140 VENOUS THROMBOSIS LIMB 7 0.0034
141 LIVER ABSCESS 11 0.0034
142 CYTOKINE RELEASE SYNDROME 68 0.0034
143 AORTIC VALVE STENOSIS 6 0.0034
144 INTRA-ABDOMINAL HAEMORRHAGE 8 0.0034
145 CHOLANGIOCARCINOMA 5 0.0034
146 ALTERED STATE OF CONSCIOUSNESS 72 0.0033
147 GASTRIC PERFORATION 9 0.0033
148 CONTRAST MEDIA ALLERGY 6 0.0033
149 DISSEMINATED INTRAVASCULAR COAGULATION 46 0.0033
150 PNEUMONIA PSEUDOMONAL 5 0.0033
151 ACUTE MYELOID LEUKAEMIA RECURRENT 7 0.0033
152 AMYLASE INCREASED 12 0.0032
153 DRUG ERUPTION 57 0.0032
154 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
155 METASTASES TO PERITONEUM 8 0.0032
156 VITAMIN B12 DECREASED 9 0.0031
157 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
158 PERIPHERAL SENSORY NEUROPATHY 18 0.0031
159 PYELONEPHRITIS ACUTE 6 0.0031
160 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
161 IGA NEPHROPATHY 5 0.0030
162 TROPONIN I INCREASED 5 0.0030
163 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
164 CEREBELLAR INFARCTION 5 0.0030
165 FEMORAL NECK FRACTURE 15 0.0029
166 INTESTINAL ISCHAEMIA 16 0.0029
167 GASTRIC ULCER HAEMORRHAGE 16 0.0029
168 GASTROINTESTINAL PERFORATION 12 0.0029
169 ATRIAL TACHYCARDIA 6 0.0029
170 DUODENAL ULCER 20 0.0028
171 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
172 SKIN EROSION 9 0.0028
173 SYSTEMIC CANDIDA 7 0.0028
174 RENAL INFARCT 4 0.0028
175 GASTROINTESTINAL NECROSIS 8 0.0027
176 ILEUS PARALYTIC 12 0.0027
177 CARDIAC DYSFUNCTION 10 0.0027
178 PSEUDOMEMBRANOUS COLITIS 6 0.0027
179 DIVERTICULUM INTESTINAL HAEMORRHAGIC 6 0.0027
180 HEPATOCELLULAR CARCINOMA 20 0.0026
181 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
182 SENSATION OF FOREIGN BODY 22 0.0026
183 OESOPHAGEAL ULCER 10 0.0026
184 NEPHROGENIC ANAEMIA 12 0.0026
185 PERFORMANCE STATUS DECREASED 12 0.0026
186 EPIGASTRIC DISCOMFORT 10 0.0026
187 FUNGAEMIA 4 0.0025
188 HAEMORRHAGE SUBCUTANEOUS 9 0.0025
189 PARONYCHIA 11 0.0025
190 TYPE 1 DIABETES MELLITUS 15 0.0025
191 PORTAL VEIN THROMBOSIS 8 0.0025
192 CHOLECYSTITIS ACUTE 14 0.0025
193 OESOPHAGEAL STENOSIS 7 0.0025
194 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 10 0.0024
195 LARGE INTESTINE PERFORATION 17 0.0024
196 SEBORRHOEIC DERMATITIS 4 0.0024
197 AORTIC DISSECTION 10 0.0024
198 LIVER DISORDER 107 0.0024
199 SUBILEUS 5 0.0024
200 THROAT CLEARING 9 0.0024
201 LYMPHOPROLIFERATIVE DISORDER 7 0.0024
202 MALIGNANT PLEURAL EFFUSION 4 0.0024
203 HYPOMAGNESAEMIA 33 0.0024
204 DYSLIPIDAEMIA 12 0.0024
205 OESOPHAGEAL DISORDER 9 0.0023
206 PERIODONTITIS 5 0.0023
207 PSEUDOMONAL SEPSIS 4 0.0023
208 PNEUMONIA FUNGAL 9 0.0023
209 IRON DEFICIENCY ANAEMIA 21 0.0023
210 EMBOLIC STROKE 8 0.0023
211 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
212 NEUTROPHIL COUNT DECREASED 91 0.0022
213 FEEDING DISORDER 45 0.0022
214 PNEUMOMEDIASTINUM 4 0.0022
215 SHOCK HAEMORRHAGIC 18 0.0022
216 VASCULAR DEVICE INFECTION 10 0.0022
217 BLOOD MAGNESIUM DECREASED 19 0.0022
218 DRUG-INDUCED LIVER INJURY 69 0.0022
219 URINE OUTPUT DECREASED 19 0.0022
220 SYMPTOM RECURRENCE 13 0.0022
221 OESOPHAGEAL SPASM 4 0.0022
222 LUPUS NEPHRITIS 4 0.0021
223 DISCOURAGEMENT 5 0.0021
224 INCORRECT PRODUCT ADMINISTRATION DURATION 46 0.0021
225 PANCREATITIS CHRONIC 5 0.0021
226 GASTRIC ULCER 40 0.0021
227 ILLNESS 216 0.0021
228 ILEUS 26 0.0021
229 LONG QT SYNDROME 5 0.0021
230 HIATUS HERNIA 27 0.0021
231 HYPERTONIC BLADDER 6 0.0021
232 TUMOUR LYSIS SYNDROME 18 0.0020
233 ERYTHEMA MULTIFORME 19 0.0020
234 RENAL IMPAIRMENT 171 0.0020
235 HYPOPHAGIA 52 0.0020
236 COVID-19 PNEUMONIA 24 0.0020
237 THORACIC VERTEBRAL FRACTURE 6 0.0020
238 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
239 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
240 BLOOD ALBUMIN DECREASED 16 0.0020
241 CHOLECYSTITIS 24 0.0020
242 CATHETER SITE HAEMORRHAGE 5 0.0020
243 LUNG ADENOCARCINOMA 6 0.0020
244 URINE ABNORMALITY 9 0.0020
245 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
246 DERMATOMYOSITIS 5 0.0020
247 DERMATITIS ACNEIFORM 12 0.0020
248 FIBRIN D DIMER INCREASED 7 0.0020
249 CARDIAC FAILURE 157 0.0020
250 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
251 DIFFUSE LARGE B-CELL LYMPHOMA 15 0.0019
252 MENINGITIS 13 0.0019
253 PHARYNGEAL SWELLING 19 0.0019
254 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
255 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
256 GASTRITIS EROSIVE 9 0.0019
257 ERUCTATION 37 0.0019
258 FOREIGN BODY IN THROAT 6 0.0019
259 NEPHROTIC SYNDROME 13 0.0019
260 NEUROGENIC BLADDER 4 0.0019
261 CARDIAC TAMPONADE 9 0.0019
262 TUMOUR MARKER INCREASED 9 0.0019
263 ANAEMIA MACROCYTIC 4 0.0019
264 PEMPHIGOID 14 0.0019
265 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
266 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
267 GASTRIC HAEMORRHAGE 21 0.0018
268 GASTROINTESTINAL PAIN 20 0.0018
269 CLOSTRIDIUM TEST POSITIVE 4 0.0018
270 HYPERAMMONAEMIA 9 0.0018
271 MENINGITIS ASEPTIC 8 0.0018
272 URINARY TRACT DISORDER 8 0.0018
273 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
274 GASTRIC CANCER 45 0.0018
275 BACTERAEMIA 21 0.0018
276 DYSPEPSIA 174 0.0018
277 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
278 PNEUMATOSIS INTESTINALIS 5 0.0018
279 HYPOCALCAEMIA 33 0.0017
280 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
281 FEBRILE NEUTROPENIA 114 0.0017
282 HEPATIC ENCEPHALOPATHY 16 0.0017
283 SPINAL COMPRESSION FRACTURE 14 0.0017
284 LACUNAR INFARCTION 4 0.0017
285 ABDOMINAL DISTENSION 172 0.0016
286 CYTOMEGALOVIRUS INFECTION 27 0.0016
287 THIRST 29 0.0016
288 WOUND HAEMORRHAGE 6 0.0016
289 C-REACTIVE PROTEIN INCREASED 59 0.0016
290 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
291 HAEMATEMESIS 41 0.0016
292 PYELONEPHRITIS 14 0.0016
293 GASTROINTESTINAL SOUNDS ABNORMAL 8 0.0016
294 HYPERNATRAEMIA 8 0.0016
295 ASCITES 47 0.0016
296 POLYMYALGIA RHEUMATICA 5 0.0016
297 GASTRITIS 41 0.0016
298 VARICOSE VEIN 8 0.0015
299 MALABSORPTION 8 0.0015
300 LYMPHOCYTE COUNT DECREASED 27 0.0015
301 POLYP 10 0.0015
302 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
303 HYPOGAMMAGLOBULINAEMIA 10 0.0015
304 FAECES DISCOLOURED 33 0.0015
305 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
306 SERUM FERRITIN INCREASED 8 0.0015
307 THROAT IRRITATION 68 0.0015
308 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
309 CORONAVIRUS INFECTION 10 0.0015
310 RENAL PAIN 16 0.0015
311 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
312 CYSTITIS HAEMORRHAGIC 6 0.0015
313 MYOCARDITIS 17 0.0015
314 METASTASES TO LYMPH NODES 10 0.0015
315 HYPOTHYROIDISM 47 0.0015
316 HYDROCEPHALUS 8 0.0015
317 HYPERKALAEMIA 51 0.0015
318 LARGE INTESTINE POLYP 10 0.0014
319 OROPHARYNGEAL DISCOMFORT 13 0.0014
320 HAEMORRHAGIC DIATHESIS 5 0.0014
321 CORONARY ARTERY STENOSIS 7 0.0014
322 TOXIC ENCEPHALOPATHY 7 0.0014
323 DIABETIC KETOACIDOSIS 33 0.0014
324 DIVERTICULUM INTESTINAL 6 0.0014
325 LUMBAR SPINAL STENOSIS 4 0.0014
326 GASTROINTESTINAL DISORDER 121 0.0013
327 HEPATITIS FULMINANT 4 0.0013
328 HYPOKALAEMIA 62 0.0013
329 APLASTIC ANAEMIA 7 0.0013
330 HYDRONEPHROSIS 10 0.0013
331 HYPERCAPNIA 4 0.0013
332 BLOOD PRESSURE DECREASED 88 0.0013
333 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
334 KERATITIS 4 0.0013
335 SEPTIC SHOCK 57 0.0013
336 STEVENS-JOHNSON SYNDROME 29 0.0013
337 PRESCRIBED UNDERDOSE 26 0.0013
338 RECTAL CANCER 4 0.0013
339 ASPIRATION 14 0.0013
340 HEPATIC CIRRHOSIS 24 0.0013
341 PLATELET COUNT DECREASED 136 0.0013
342 VENOUS THROMBOSIS 5 0.0013
343 MELAENA 28 0.0013
344 HYPOVOLAEMIC SHOCK 6 0.0013
345 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
346 BLEPHARITIS 5 0.0012
347 FAECES SOFT 9 0.0012
348 FLATULENCE 70 0.0012
349 DEVICE RELATED INFECTION 19 0.0012
350 TASTE DISORDER 25 0.0012
351 BACTERIAL SEPSIS 4 0.0012
352 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
353 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
354 MYOSITIS 11 0.0012
355 ABNORMAL FAECES 10 0.0012
356 ABDOMINAL PAIN UPPER 251 0.0012
357 ARTHRITIS BACTERIAL 5 0.0012
358 DEAFNESS NEUROSENSORY 4 0.0012
359 NEAR DEATH EXPERIENCE 4 0.0012
360 PEPTIC ULCER 4 0.0012
361 STRESS CARDIOMYOPATHY 7 0.0012
362 EOSINOPHIL COUNT INCREASED 10 0.0012
363 SUBDURAL HAEMATOMA 17 0.0012
364 DECREASED APPETITE 272 0.0012
365 LEFT VENTRICULAR FAILURE 4 0.0012
366 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
367 ENCEPHALITIS 8 0.0012
368 MONOPLEGIA 5 0.0011
369 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
370 BRAIN FOG 18 0.0011
371 DEFAECATION URGENCY 8 0.0011
372 ORAL CANDIDIASIS 15 0.0011
373 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
374 ANAPHYLACTIC SHOCK 29 0.0011
375 JAUNDICE 30 0.0011
376 ASPARTATE AMINOTRANSFERASE INCREASED 59 0.0011
377 CHEILITIS 6 0.0011
378 SUSPECTED OFF LABEL USE 5 0.0011
379 HYPERTHYROIDISM 16 0.0011
380 PROTEINURIA 21 0.0011
381 PLEURAL EFFUSION 67 0.0011
382 SCLERODERMA 4 0.0011
383 CAROTID ARTERY OCCLUSION 4 0.0011
384 HAEMOGLOBIN INCREASED 5 0.0011
385 INTENTIONAL UNDERDOSE 8 0.0011
386 FAECALOMA 6 0.0011
387 VENTRICULAR TACHYCARDIA 18 0.0011
388 ACUTE MYOCARDIAL INFARCTION 32 0.0011
389 UNEVALUABLE EVENT 82 0.0011
390 HYPOPHOSPHATAEMIA 8 0.0011
391 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
392 METASTASES TO LIVER 19 0.0011
393 VENTRICULAR FIBRILLATION 12 0.0011
394 HEPATITIS ACUTE 7 0.0011
395 COLON CANCER 16 0.0011
396 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
397 APPENDICITIS 10 0.0011
398 AUTOIMMUNE THYROIDITIS 4 0.0011
399 HYPERCALCAEMIA 13 0.0011
400 PSEUDOMONAS INFECTION 9 0.0010
401 HYPONATRAEMIA 59 0.0010
402 CLAVICLE FRACTURE 4 0.0010
403 BLOOD URIC ACID INCREASED 6 0.0010
404 DELIRIUM 36 0.0010
405 MYELODYSPLASTIC SYNDROME 15 0.0010
406 METASTASES TO BONE 17 0.0010
407 GUILLAIN-BARRE SYNDROME 5 0.0010
408 MYELOSUPPRESSION 37 0.0010
409 PANCREATITIS ACUTE 23 0.0010
410 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
411 BLOOD UREA INCREASED 17 0.0010
412 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
413 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
414 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
415 PLEURISY 6 0.0010
416 FOOT OPERATION 5 0.0010
417 INFLAMMATORY MARKER INCREASED 5 0.0010
418 ORAL DISCOMFORT 14 0.0010
419 ANAL INCONTINENCE 9 0.0010
420 RIGHT VENTRICULAR FAILURE 7 0.0010
421 ANAEMIA 188 0.0010
422 PANCYTOPENIA 55 0.0010
423 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
424 HELICOBACTER INFECTION 10 0.0010
425 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
426 PERITONITIS 20 0.0010
427 BLOOD POTASSIUM DECREASED 29 0.0010
428 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
429 SWELLING OF EYELID 6 0.0010
430 AORTIC VALVE INCOMPETENCE 4 0.0009
431 STOMATITIS 57 0.0009
432 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
433 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
434 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
435 ALANINE AMINOTRANSFERASE INCREASED 57 0.0009
436 PRODUCT RESIDUE PRESENT 5 0.0009
437 BLOOD BILIRUBIN INCREASED 25 0.0009
438 DEHYDRATION 123 0.0009
439 MALIGNANT NEOPLASM PROGRESSION 94 0.0009
440 SHOCK 21 0.0009
441 POLLAKIURIA 38 0.0009
442 CHOKING SENSATION 5 0.0009
443 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
444 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
445 PURPURA 8 0.0009
446 WHITE BLOOD CELL COUNT DECREASED 98 0.0009
447 RENAL DISORDER 42 0.0009
448 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 21 0.0009
449 FUNGAL INFECTION 30 0.0009
450 URINARY RETENTION 30 0.0009
451 CARDIOMEGALY 11 0.0009
452 ABDOMINAL DISCOMFORT 150 0.0009
453 TOXIC SKIN ERUPTION 9 0.0009
454 GASTROENTERITIS 13 0.0009
455 FACE OEDEMA 15 0.0009
456 PERIORBITAL SWELLING 5 0.0009
457 SUBARACHNOID HAEMORRHAGE 9 0.0009
458 HYPOXIA 31 0.0009
459 IMPAIRED GASTRIC EMPTYING 12 0.0009
460 MYOCARDIAL ISCHAEMIA 10 0.0009
461 LUMBAR VERTEBRAL FRACTURE 4 0.0009
462 FLANK PAIN 8 0.0009
463 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 60 0.0008
464 HEMIPLEGIA 7 0.0008
465 LYMPHOMA 13 0.0008
466 PROTHROMBIN TIME PROLONGED 5 0.0008
467 PULMONARY CONGESTION 11 0.0008
468 DECREASED ACTIVITY 9 0.0008
469 HYPERCHOLESTEROLAEMIA 8 0.0008
470 HYPERGLYCAEMIA 30 0.0008
471 INGUINAL HERNIA 5 0.0008
472 FACIAL PARALYSIS 7 0.0008
473 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
474 CYTOPENIA 10 0.0008
475 PULMONARY HYPERTENSION 17 0.0008
476 DIARRHOEA 526 0.0008
477 OEDEMA 44 0.0008
478 MUCOUS STOOLS 4 0.0008
479 FEMUR FRACTURE 25 0.0008
480 BLADDER DISORDER 8 0.0008
481 KETOACIDOSIS 6 0.0008
482 ERYSIPELAS 4 0.0008
483 PALPITATIONS 93 0.0008
484 KLEBSIELLA INFECTION 4 0.0008
485 PRODUCT DOSE OMISSION ISSUE 232 0.0008
486 INTERNAL HAEMORRHAGE 9 0.0008
487 DRY THROAT 8 0.0008
488 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
489 BOWEL MOVEMENT IRREGULARITY 6 0.0008
490 HERPES ZOSTER 45 0.0008
491 ENDOCARDITIS 4 0.0008
492 CONSTIPATION 170 0.0008
493 METASTASES TO LUNG 9 0.0008
494 CHOKING 15 0.0008
495 COLITIS 29 0.0008
496 HYPOGLYCAEMIA 37 0.0008
497 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
498 FOOD CRAVING 4 0.0008
499 PNEUMOTHORAX 12 0.0008
500 GINGIVAL PAIN 6 0.0008
501 BODY HEIGHT DECREASED 8 0.0007
502 NOCTURIA 9 0.0007
503 COLITIS ISCHAEMIC 5 0.0007
504 FRACTURE 14 0.0007
505 DECUBITUS ULCER 6 0.0007
506 ASPHYXIA 6 0.0007
507 PYREXIA 253 0.0007
508 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
509 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
510 CEREBRAL HAEMORRHAGE 26 0.0007
511 RESPIRATION ABNORMAL 5 0.0007
512 DRUG LEVEL INCREASED 12 0.0007
513 PRESCRIBED OVERDOSE 14 0.0007
514 MALAISE 317 0.0007
515 SECOND PRIMARY MALIGNANCY 6 0.0007
516 THROMBOTIC MICROANGIOPATHY 7 0.0007
517 AUTOIMMUNE DISORDER 7 0.0007
518 MACULAR OEDEMA 4 0.0007
519 INFUSION RELATED REACTION 47 0.0007
520 DYSURIA 26 0.0007
521 ACUTE MYELOID LEUKAEMIA 11 0.0007
522 RETINAL HAEMORRHAGE 5 0.0007
523 HEPATIC FAILURE 21 0.0007
524 MOUTH SWELLING 4 0.0007
525 METABOLIC DISORDER 4 0.0007
526 ABDOMINAL PAIN 160 0.0007
527 DIVERTICULITIS 19 0.0007
528 DRUG INTERACTION 108 0.0007
529 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
530 FACIAL PAIN 6 0.0007
531 RHABDOMYOLYSIS 28 0.0007
532 CARDIO-RESPIRATORY ARREST 28 0.0007
533 HYPERLIPIDAEMIA 8 0.0007
534 GASTROINTESTINAL INFECTION 6 0.0007
535 THROAT TIGHTNESS 18 0.0007
536 CHROMATURIA 15 0.0007
537 CHEST PAIN 123 0.0007
538 HYPOAESTHESIA ORAL 10 0.0007
539 URINARY TRACT INFECTION 113 0.0007
540 SUDDEN DEATH 7 0.0007
541 ACUTE HEPATIC FAILURE 9 0.0007
542 RETCHING 14 0.0007
543 SEPSIS 73 0.0007
544 RETINAL DETACHMENT 6 0.0007
545 DYSPHONIA 38 0.0006
546 LACTIC ACIDOSIS 21 0.0006
547 PHARYNGITIS 8 0.0006
548 OLIGURIA 4 0.0006
549 COVID-19 113 0.0006
550 TORSADE DE POINTES 5 0.0006
551 HYPERTENSION 135 0.0006
552 PNEUMONIA 205 0.0006
553 BLOOD URINE PRESENT 12 0.0006
554 UNDERDOSE 46 0.0006
555 RENAL CYST 5 0.0006
556 CYSTITIS 20 0.0006
557 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
558 ENTERITIS 4 0.0006
559 TRANSPLANT REJECTION 5 0.0006
560 GLAUCOMA 12 0.0006
561 MOVEMENT DISORDER 20 0.0006
562 PROCTALGIA 4 0.0006
563 ATELECTASIS 6 0.0006
564 HEART RATE IRREGULAR 14 0.0006
565 CARDIAC FLUTTER 4 0.0006
566 DIZZINESS POSTURAL 6 0.0006
567 BLOOD POTASSIUM INCREASED 10 0.0006
568 ANGINA UNSTABLE 4 0.0006
569 MICTURITION URGENCY 7 0.0006
570 NAUSEA 485 0.0006
571 BLOOD CREATININE INCREASED 40 0.0006
572 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
573 HICCUPS 5 0.0006
574 BLOOD PRESSURE INCREASED 93 0.0006
575 OSTEOPOROSIS 25 0.0006
576 OSTEOMYELITIS 11 0.0006
577 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
578 MUSCULAR WEAKNESS 69 0.0006
579 MUSCLE SPASMS 111 0.0006
580 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
581 POST PROCEDURAL HAEMORRHAGE 7 0.0006
582 DYSPHAGIA 57 0.0006
583 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
584 HAEMATOCHEZIA 33 0.0006
585 SPLENOMEGALY 7 0.0006
586 OFF LABEL USE 520 0.0006
587 ANGINA PECTORIS 17 0.0006
588 DYSGEUSIA 44 0.0006
589 HEPATIC STEATOSIS 11 0.0006
590 EYELID PTOSIS 6 0.0006
591 BLOOD IRON DECREASED 7 0.0006
592 UVEITIS 8 0.0006
593 MIDDLE INSOMNIA 11 0.0006
594 EPILEPSY 18 0.0006
595 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 106 0.0006
596 PNEUMONITIS 16 0.0006
597 PRODUCTIVE COUGH 28 0.0006
598 HOSPITALISATION 90 0.0006
599 EAR DISCOMFORT 6 0.0006
600 LUNG NEOPLASM MALIGNANT 24 0.0006
601 ACUTE KIDNEY INJURY 89 0.0006
602 AUTOIMMUNE HEPATITIS 4 0.0006
603 SKIN DISORDER 19 0.0006
604 COLD SWEAT 10 0.0006
605 OEDEMA PERIPHERAL 69 0.0006
606 GENERALISED OEDEMA 7 0.0006
607 PAIN IN JAW 16 0.0006
608 DISCOMFORT 34 0.0006
609 INTESTINAL OBSTRUCTION 21 0.0006
610 CELLULITIS 28 0.0006
611 MUSCLE TIGHTNESS 9 0.0006
612 HAEMATURIA 19 0.0006
613 DRY MOUTH 45 0.0006
614 PARAESTHESIA ORAL 8 0.0006
615 BRAIN OEDEMA 7 0.0006
616 DERMATITIS BULLOUS 4 0.0006
617 LIP DRY 5 0.0005
618 RESPIRATORY FAILURE 40 0.0005
619 PRODUCT PRESCRIBING ERROR 13 0.0005
620 MOUTH HAEMORRHAGE 4 0.0005
621 MALNUTRITION 6 0.0005
622 PAROSMIA 4 0.0005
623 OROPHARYNGEAL PAIN 49 0.0005
624 CIRCULATORY COLLAPSE 9 0.0005
625 ARRHYTHMIA 25 0.0005
626 DIABETES MELLITUS 40 0.0005
627 HYPERTHERMIA 4 0.0005
628 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
629 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
630 ACIDOSIS 4 0.0005
631 LIPASE INCREASED 4 0.0005
632 HAEMOLYSIS 4 0.0005
633 CHEST DISCOMFORT 53 0.0005
634 ATRIOVENTRICULAR BLOCK 4 0.0005
635 EJECTION FRACTION DECREASED 8 0.0005
636 VOMITING 242 0.0005
637 IRRITABLE BOWEL SYNDROME 11 0.0005
638 HAEMOPTYSIS 14 0.0005
639 SALIVARY HYPERSECRETION 5 0.0005
640 RHINITIS 4 0.0005
641 DEEP VEIN THROMBOSIS 32 0.0005
642 ORAL PAIN 11 0.0005
643 SLUGGISHNESS 5 0.0005
644 HYPERBILIRUBINAEMIA 5 0.0005
645 GAIT INABILITY 16 0.0005
646 SURGERY 28 0.0005
647 BLOOD SODIUM DECREASED 9 0.0005
648 TRANSFUSION 5 0.0005
649 PERICARDIAL EFFUSION 11 0.0005
650 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
651 ATRIAL FIBRILLATION 46 0.0005
652 INCREASED APPETITE 9 0.0005
653 IMMUNODEFICIENCY 7 0.0005
654 RESPIRATORY DISORDER 14 0.0005
655 LIVER FUNCTION TEST INCREASED 10 0.0005
656 INFLAMMATION 24 0.0005
657 DISEASE PROGRESSION 55 0.0005
658 MUSCULOSKELETAL DISCOMFORT 8 0.0005
659 OXYGEN SATURATION DECREASED 26 0.0005
660 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
661 CARDIAC FAILURE CONGESTIVE 37 0.0005
662 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
663 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
664 BURNING SENSATION 32 0.0005
665 INTENTIONAL DOSE OMISSION 13 0.0005
666 HEPATIC ENZYME INCREASED 31 0.0005
667 IMMUNOSUPPRESSION 4 0.0005
668 DENTAL CARIES 5 0.0005
669 DYSPNOEA EXERTIONAL 17 0.0005
670 MIGRAINE 43 0.0004
671 HYPOAESTHESIA 67 0.0004
672 HAEMOLYTIC ANAEMIA 4 0.0004
673 BLOOD CALCIUM DECREASED 5 0.0004
674 FREQUENT BOWEL MOVEMENTS 12 0.0004
675 BONE PAIN 26 0.0004
676 GASTROENTERITIS VIRAL 8 0.0004
677 INSOMNIA 118 0.0004
678 DYSKINESIA 18 0.0004
679 FEELING ABNORMAL 106 0.0004
680 OPTIC NEURITIS 4 0.0004
681 ULCER 7 0.0004
682 RIB FRACTURE 9 0.0004
683 PERIPHERAL COLDNESS 6 0.0004
684 SENSORY DISTURBANCE 7 0.0004
685 BRAIN NEOPLASM 4 0.0004
686 RESPIRATORY ARREST 12 0.0004
687 HEADACHE 271 0.0004
688 HUNGER 6 0.0004
689 APHONIA 6 0.0004
690 DEMENTIA 12 0.0004
691 VASCULITIS 5 0.0004
692 DIZZINESS 214 0.0004
693 DIARRHOEA HAEMORRHAGIC 4 0.0004
694 COLITIS ULCERATIVE 19 0.0004
695 ARTERIOSCLEROSIS 4 0.0004
696 FALL 141 0.0004
697 EATING DISORDER 9 0.0004
698 FOOT FRACTURE 8 0.0004
699 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
700 CHOLESTASIS 8 0.0004
701 HEPATITIS C 5 0.0004
702 FLUID RETENTION 21 0.0004
703 PRESYNCOPE 10 0.0004
704 BACK PAIN 95 0.0004
705 INFLAMMATORY BOWEL DISEASE 4 0.0004
706 DISORIENTATION 16 0.0004
707 ECZEMA 21 0.0004
708 AGEUSIA 10 0.0004
709 BRADYCARDIA 21 0.0004
710 HEAD DISCOMFORT 7 0.0004
711 MOTOR DYSFUNCTION 4 0.0004
712 MUSCLE TWITCHING 9 0.0004
713 LIP SWELLING 13 0.0004
714 HAEMOGLOBIN DECREASED 40 0.0004
715 PULMONARY EMBOLISM 37 0.0004
716 SKIN ULCER 10 0.0004
717 NERVOUS SYSTEM DISORDER 12 0.0004
718 END STAGE RENAL DISEASE 7 0.0004
719 LOSS OF CONSCIOUSNESS 49 0.0004
720 MYALGIA 65 0.0004
721 MOUTH ULCERATION 8 0.0004
722 IMMUNE SYSTEM DISORDER 5 0.0004
723 SARS-COV-2 TEST POSITIVE 5 0.0004
724 PANCREATITIS 20 0.0004
725 DYSPNOEA 214 0.0004
726 BLOOD PRESSURE FLUCTUATION 9 0.0004
727 COUGH 105 0.0004
728 POOR QUALITY SLEEP 8 0.0004
729 RASH 161 0.0004
730 CORONARY ARTERY OCCLUSION 5 0.0004
731 STAPHYLOCOCCAL INFECTION 12 0.0004
732 OSTEONECROSIS OF JAW 9 0.0004
733 PRURITUS 138 0.0004
734 ORAL HERPES 7 0.0004
735 ARTHRALGIA 149 0.0004
736 GLOSSODYNIA 8 0.0004
737 PULMONARY OEDEMA 16 0.0004
738 INTESTINAL PERFORATION 4 0.0004
739 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
740 SEASONAL ALLERGY 5 0.0004
741 SCAB 4 0.0004
742 CHILLS 41 0.0003
743 NEUROPATHY PERIPHERAL 33 0.0003
744 DRUG INEFFECTIVE 457 0.0003
745 SEIZURE 40 0.0003
746 PANCREATIC CARCINOMA 10 0.0003
747 ORTHOSTATIC HYPOTENSION 6 0.0003
748 PERIPHERAL SWELLING 53 0.0003
749 VISION BLURRED 47 0.0003
750 CHRONIC KIDNEY DISEASE 26 0.0003
751 CARDIAC ARREST 28 0.0003
752 CARDIOMYOPATHY 5 0.0003
753 BRONCHITIS 25 0.0003
754 WHEEZING 20 0.0003
755 OESOPHAGEAL CARCINOMA 10 0.0003
756 ASTHMA 38 0.0003
757 CHOLELITHIASIS 11 0.0003
758 DERMATITIS 7 0.0003
759 WEIGHT DECREASED 93 0.0003
760 TOOTHACHE 6 0.0003
761 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
762 ERYTHEMA 68 0.0003
763 MENTAL IMPAIRMENT 8 0.0003
764 NEURALGIA 8 0.0003
765 VERTIGO 20 0.0003
766 THYROID DISORDER 5 0.0003
767 FEELING COLD 9 0.0003
768 MUSCULOSKELETAL CHEST PAIN 5 0.0003
769 AGRANULOCYTOSIS 6 0.0003
770 BACTERIAL INFECTION 6 0.0003
771 PEMPHIGUS 4 0.0003
772 SECRETION DISCHARGE 4 0.0003
773 NEOPLASM PROGRESSION 11 0.0003
774 HEAD INJURY 10 0.0003
775 FEELING JITTERY 6 0.0003
776 RESPIRATORY TRACT CONGESTION 5 0.0003
777 RASH MACULO-PAPULAR 7 0.0003
778 SOMNOLENCE 63 0.0003
779 WEIGHT INCREASED 70 0.0003
780 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
781 HERNIA 6 0.0003
782 SWELLING 29 0.0003
783 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
784 RENAL FAILURE 41 0.0003
785 EAR PAIN 6 0.0003
786 DYSSTASIA 9 0.0003
787 HAEMORRHOIDS 6 0.0003
788 BACK DISORDER 5 0.0003
789 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
790 OSTEONECROSIS 10 0.0003
791 TACHYCARDIA 27 0.0003
792 BLOOD PRESSURE ABNORMAL 6 0.0003
793 COAGULOPATHY 5 0.0003
794 NEOPLASM MALIGNANT 20 0.0003
795 MENTAL DISORDER 13 0.0003
796 JOINT RANGE OF MOTION DECREASED 4 0.0003
797 PRODUCT USE ISSUE 56 0.0003
798 INFECTION 43 0.0003
799 EPISTAXIS 22 0.0003
800 PALLOR 8 0.0003
801 PAIN 180 0.0003
802 SWELLING FACE 19 0.0003
803 PROCEDURAL PAIN 8 0.0003
804 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
805 THROMBOCYTOPENIA 32 0.0003
806 BLISTER 16 0.0003
807 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
808 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
809 DRY EYE 14 0.0003
810 CARDIOGENIC SHOCK 4 0.0003
811 BALANCE DISORDER 24 0.0003
812 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
813 TREMOR 46 0.0003
814 RASH PRURITIC 15 0.0003
815 PRODUCT PRESCRIBING ISSUE 6 0.0003
816 APATHY 4 0.0003
817 HYPOTENSION 55 0.0003
818 TREATMENT NONCOMPLIANCE 15 0.0003
819 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
820 CONDITION AGGRAVATED 82 0.0003
821 DIPLOPIA 7 0.0003
822 GENERAL PHYSICAL HEALTH DETERIORATION 31 0.0003
823 HAEMORRHAGE INTRACRANIAL 4 0.0003
824 SNEEZING 6 0.0003
825 PARAESTHESIA 42 0.0003
826 NEUTROPENIA 36 0.0003
827 ROAD TRAFFIC ACCIDENT 11 0.0003
828 SLEEP APNOEA SYNDROME 5 0.0003
829 INSURANCE ISSUE 4 0.0003
830 LOWER LIMB FRACTURE 5 0.0003
831 PAIN IN EXTREMITY 76 0.0003
832 SWOLLEN TONGUE 8 0.0003
833 PRODUCT USE COMPLAINT 4 0.0003
834 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
835 ABNORMAL DREAMS 7 0.0003
836 ANAPHYLACTIC REACTION 14 0.0003
837 HEART RATE INCREASED 25 0.0003
838 NECK PAIN 14 0.0003
839 HAEMORRHAGE 26 0.0002
840 JOINT SWELLING 30 0.0002
841 MUSCULOSKELETAL PAIN 13 0.0002
842 FULL BLOOD COUNT DECREASED 5 0.0002
843 FIBROMYALGIA 6 0.0002
844 RESTLESSNESS 9 0.0002
845 LUNG DISORDER 12 0.0002
846 RED BLOOD CELL COUNT DECREASED 7 0.0002
847 INFLUENZA LIKE ILLNESS 20 0.0002
848 VISUAL ACUITY REDUCED 8 0.0002
849 ABDOMINAL PAIN LOWER 6 0.0002
850 BLOOD CHOLESTEROL INCREASED 11 0.0002
851 ERECTILE DYSFUNCTION 6 0.0002
852 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
853 CORONARY ARTERY DISEASE 7 0.0002
854 THERAPEUTIC RESPONSE DECREASED 14 0.0002
855 FEELING HOT 14 0.0002
856 LIMB DISCOMFORT 7 0.0002
857 ANGIOEDEMA 10 0.0002
858 SKIN EXFOLIATION 19 0.0002
859 HYPERHIDROSIS 29 0.0002
860 DRY SKIN 30 0.0002
861 RASH PAPULAR 5 0.0002
862 RESTLESS LEGS SYNDROME 4 0.0002
863 METABOLIC ACIDOSIS 7 0.0002
864 MYOCARDIAL INFARCTION 38 0.0002
865 TINNITUS 10 0.0002
866 NASOPHARYNGITIS 40 0.0002
867 DEATH 186 0.0002
868 HYPERSENSITIVITY 40 0.0002
869 EYE SWELLING 8 0.0002
870 ANXIETY 61 0.0002
871 GAIT DISTURBANCE 41 0.0002
872 EYE PAIN 12 0.0002
873 PROSTATE CANCER 17 0.0002
874 OCULAR HYPERAEMIA 10 0.0002
875 NERVOUSNESS 11 0.0002
876 VIRAL INFECTION 7 0.0002
877 ASTHENIA 79 0.0002
878 SKIN BURNING SENSATION 15 0.0002
879 FATIGUE 163 0.0002
880 URTICARIA 35 0.0002
881 PULMONARY FIBROSIS 4 0.0002
882 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
883 HAEMATOCRIT DECREASED 4 0.0002
884 CATARACT 12 0.0002
885 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
886 RASH MACULAR 7 0.0002
887 APHASIA 6 0.0002
888 LYMPHADENOPATHY 7 0.0002
889 BONE MARROW FAILURE 4 0.0002
890 NEPHROLITHIASIS 9 0.0002
891 SKIN DISCOLOURATION 9 0.0002
892 HEPATITIS 5 0.0002
893 EXPOSURE VIA SKIN CONTACT 5 0.0002
894 COGNITIVE DISORDER 9 0.0002
895 SYNCOPE 19 0.0002
896 OSTEOARTHRITIS 8 0.0002
897 JOINT INJURY 4 0.0002
898 NASAL CONGESTION 11 0.0002
899 FLUSHING 19 0.0002
900 NIGHT SWEATS 6 0.0002
901 DYSARTHRIA 7 0.0002
902 FEAR 5 0.0002
903 PAIN OF SKIN 5 0.0002
904 SINUSITIS 19 0.0002
905 MUSCULOSKELETAL STIFFNESS 16 0.0002
906 INFLUENZA 20 0.0002
907 WOUND 5 0.0002
908 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
909 LETHARGY 10 0.0002
910 HALLUCINATION 13 0.0002
911 RHINORRHOEA 11 0.0002
912 URINARY INCONTINENCE 5 0.0002
913 MOBILITY DECREASED 12 0.0002
914 DISTURBANCE IN ATTENTION 9 0.0002
915 WITHDRAWAL SYNDROME 7 0.0002
916 HEPATIC CANCER 4 0.0002
917 ARTHRITIS 13 0.0002
918 RECTAL HAEMORRHAGE 7 0.0002
919 ENCEPHALOPATHY 4 0.0002
920 HYPOACUSIS 7 0.0002
921 THROMBOSIS 13 0.0002
922 BONE DENSITY DECREASED 5 0.0002
923 HOT FLUSH 12 0.0002
924 CARDIOVASCULAR DISORDER 4 0.0002
925 SLEEP DISORDER 11 0.0002
926 DRUG RESISTANCE 4 0.0002
927 DEPRESSION 35 0.0002
928 AMNESIA 10 0.0002
929 RESPIRATORY TRACT INFECTION 4 0.0002
930 SEDATION 4 0.0002
931 JOINT STIFFNESS 4 0.0002
932 DEPRESSED MOOD 8 0.0002
933 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
934 IRRITABILITY 9 0.0001
935 CARDIAC DISORDER 14 0.0001
936 TYPE 2 DIABETES MELLITUS 5 0.0001
937 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
938 MOOD ALTERED 4 0.0001
939 RASH ERYTHEMATOUS 7 0.0001
940 CONTUSION 14 0.0001
941 NIGHTMARE 5 0.0001
942 INJECTION SITE SWELLING 11 0.0001
943 HEART RATE DECREASED 5 0.0001
944 THERAPY INTERRUPTED 10 0.0001
945 EYE IRRITATION 8 0.0001
946 LIVER FUNCTION TEST ABNORMAL 4 0.0001
947 OVERDOSE 29 0.0001
948 THERAPY NON-RESPONDER 6 0.0001
949 DERMATITIS ATOPIC 7 0.0001
950 BLOOD GLUCOSE INCREASED 25 0.0001
951 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
952 BREAST CANCER 12 0.0001
953 PLASMA CELL MYELOMA 5 0.0001
954 ALOPECIA 25 0.0001
955 INTENTIONAL OVERDOSE 8 0.0001
956 INJECTION SITE PAIN 38 0.0001
957 IMPAIRED HEALING 4 0.0001
958 EYE DISORDER 4 0.0001
959 VISUAL IMPAIRMENT 15 0.0001
960 SPEECH DISORDER 6 0.0001
961 INJECTION SITE BRUISING 9 0.0001
962 PANIC ATTACK 4 0.0001
963 SKIN IRRITATION 5 0.0001
964 RHEUMATOID ARTHRITIS 12 0.0001
965 INJECTION SITE ERYTHEMA 13 0.0001
966 BLOOD GLUCOSE DECREASED 5 0.0001
967 INTENTIONAL PRODUCT MISUSE 9 0.0001
968 INJECTION SITE REACTION 7 0.0001
969 ABNORMAL BEHAVIOUR 4 0.0001
970 ADVERSE EVENT 9 0.0001
971 TOXICITY TO VARIOUS AGENTS 14 0.0001
972 SUICIDE ATTEMPT 5 0.0001
973 LEUKOPENIA 4 0.0001
974 ACNE 6 0.0001
975 INCORRECT DOSE ADMINISTERED 18 0.0001
976 DRUG INTOLERANCE 7 0.0001
977 TREATMENT FAILURE 6 0.0001
978 MEDICATION ERROR 4 0.0001
979 NO ADVERSE EVENT 13 0.0001
980 AGITATION 5 0.0001
981 BLADDER CANCER 4 0.0001
982 EMOTIONAL DISTRESS 8 0.0001
983 PSORIASIS 8 0.0001
984 MEMORY IMPAIRMENT 8 0.0001
985 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
986 INJURY 4 0.0001
987 INJECTION SITE HAEMORRHAGE 4 0.0001
988 DEVICE ISSUE 4 0.0000
989 ADVERSE DRUG REACTION 4 0.0000
990 CONFUSIONAL STATE 5 0.0000